Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

genmab

Genmab Darzalex success triggers second milestone payment

March 10, 2016 Research and Development, Sales and Marketing Genmab, Janssen, daratumumab, darzalex, follicular lymphoma

Genmab says it has reached a $5 million milestone in its daratumumab collaboration with Janssen as a result of success …
News
shire_image_4

Shire launches long-acting ADHD drug in UK

March 9, 2016 Sales and Marketing ADHD, Shire

Shire has launched its long-acting ADHD drug Intuniv (guanfacine) in the UK, for children and adolescents aged 6-17. The treatment …
News
amgen_sign_on_wall

Amgen open to larger M&A deals, says CFO

March 8, 2016 Sales and Marketing Amgen, mergers and acquisitions

Amgen’s chief financial officer has indicated that the company is ready to consider doing larger deals to buy other companies, …
News
sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016 Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
News

Merck posts 15% rise in Q4 profits driven by Sigma-Aldrich acquisition

March 8, 2016 Manufacturing and Production, Sales and Marketing

German drug maker Merck on Tuesday said it sees the acquisition of Sigma-Aldrich to aid sales in 2016 and reported …
News
sensimed_lens

Wireless contact lens sensor approved by FDA

March 8, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

The US Food and Drug Administration has allowed the marketing of a contact lens sensor that may help practitioners identify …
News
abbvie

AbbVie pays $595m upfront for experimental Boehringer psoriasis drug

March 8, 2016 Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, BI 655066, Boehringer Ingelheim, psoriasis

AbbVie is betting big on the future of an experimental psoriasis drug, paying $595m upfront for the rights to Boehringer …
News
abbvie_0

AbbVie’s Imbruvica gets US FDA okay as first-line treatment for CLL

March 7, 2016 Sales and Marketing AbbVie, Janssen, Janssen Biotech, US FDA, imbruvica

Drug maker AbbVie said the US Food and Drug Administration (FDA) has approved its Imbruvica (ibrutinib) as a first-line treatment …
News
eli_lilly

Eli Lilly’s plaque psoriasis treatment impresses in Phase III trials

March 7, 2016 Research and Development, Sales and Marketing Eli Lilly, Enbrel, ixekizumab, psoriasis

Eli Lilly has announced late-stage trial data showing ixekuzimab treatment resulted in clinically meaningful improvements in as early as one …
News
rd_hands

Japan’s Ono Pharma focusing on building immuno-oncology portfolio with Opdivo

March 7, 2016 Sales and Marketing Bristol-Myers Sqibb, Ono Pharma, immuno-oncology, opdivo

Japan’s Ono Pharmaceutical has said it is focused on building on its immuno-oncology portfolio following the success of its PD-1 …
News
novo_nordisk

Novo Nordisk reports five-year Victoza cardiovascular safety data

March 7, 2016 Research and Development, Sales and Marketing Novo Nordisk, Victoza

Novo Nordisk has announced the top-line results from a trial investigating the cardiovascular safety of Victoza (liraglutide [rDNA origin] injection) …
News
csl_behring

FDA approves CSL Behring’s new haemophilia B treatment

March 7, 2016 Research and Development, Sales and Marketing CSL Behring, haemophilia

The US Food and Drug Administration (FDA) has approved CSL Behring’s Idelvion (Coagulation Factor IX (Recombinant)), a novel, long-acting albumin …
News

Novartis says its psoriasis drug bests Janssen’s in comparison study

March 7, 2016 Research and Development, Sales and Marketing Cosentyx, Novartis, Stelara

Novartis has announced new data from a study comparing its drug Cosentyx to Janssen’s Stelara, which it says demonstrates Cosentyx’s …
News
baxalta

Baxalta seeks European marketing rights for haemophilia drug

March 3, 2016 Research and Development, Sales and Marketing Adynovi haemophilia a, Baxalta

Baxalta says it has filed for marketing authorisation for its haemophilia drug Adynovi with European regulators. The European Medicines Agency …
News
ucb_logo_and_chief_executive

UCB targets regulatory filing for its osteoporosis drug in 2016

March 3, 2016 Medical Communications, Research and Development, Sales and Marketing Romosozumab, UCB Pharma, osteoporosis

Belgian drug company UCB says it is looking at a regulatory filing for its trial drug romosozumab to treat osteoporosis …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026